Fig. 1 · Structure
Documents & Downloads
QS-21-Xyl
Adjuvant
QS-21-Xyl is an immune adjuvant that enhances T-cell and B-cell responses. By activating dendritic cells, it promotes effective antigen presentation, thereby improving vaccine immunogenicity. This compound has significant potential for research applications in oncology vaccines, such as melanoma, as well as in vaccines targeting infectious diseases, including HIV and malaria.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 250643-56-2 |
| Applications | Adjuvant |
| Formula | C92H148O46 |
| Molecular Weight | 1990.13 |
| SMILES | O[C@H]([C@@H]([C@H]([C@@H](O1)C)O[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O)O)[C@@H]1O[C@H]([C@H]([C@H]([C@H](O4)C)OC(C[C@@H](O)C[C@@H]([C@@H](C)CC)OC(C[C@@H](O)C[C@@H]([C@@H](C)CC)O[C@@H]5O[C@H]([C@@H]([C@H]5O)O)CO)=O)=O)O)[C@@H]4OC([C@]67[C@](CC(C)(CC7)C)([H])C8=CC[C@@]([C@@]9([C@@]([C@@](C)([C@H](CC9)O[C@H]%10[C@@H]([C@H]([C@@H]([C@H](O%10)C(O)=O)O)O[C@H]%11[C@@H]([C@H]([C@@H](CO%11)O)O)O)O[C@@H]%12O[C@@H]([C@@H]([C@@H]([C@H]%12O)O)O)CO)C=O)([H])CC%13)C)([H])[C@]%13(C)[C@@]8(C[C@H]6O)C)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.